Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

British Journal of Cancer

Volumn 96, Issue 2, 2007, Pages 352-356

  Georgitsi, M ^a   Karhu, A ^a   Winqvist, R ^b   Visakorpi, T ^c   Waltering, K ^c   Vahteristo, P ^a   Launonen, V ^a   Aaltonen, L A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

AIP; Breast tumours; Colorectal tumours; PAP; Pituitary adenoma; Prostate tumours

Indexed keywords

ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SOMATIC MUTATION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROSTATIC NEOPLASMS; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33846527855     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603573     Document Type: Article

References (30)

1. Aaltonen LA, Salovaara R, Kristo P (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338: 1481-1487
2. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91: 1922-1932
3. Avizienyte E, Loukola A, Roth S (1999) LKB1 somatic mutations in sporadic tumors. Am J Pathol 154: 677-681
4. Bolger JB, Peden A, Steele MR (2003) Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 278: 33351- 33363, doi:10.1074/jbc.M303269200
5. Carver LA, Bradfield CA (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272: 11452-11456
6. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer: a prospective study. Science 279: 563- 566, doi: 10.1126/science.279.5350.563
7. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25: 102-152, doi:10.1210/er.2002-0022
8. Eltom SE, Gasmelseed AA, Saoudi-Guentri D (2006) The aryl hydrocarbon receptor is over-expressed and constitutively activated in advanced breast carcinoma. Proc Am Assoc Cancer Res 47: 408
9. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C (1994) BRCA 1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, doi:10.1126/science.7939630
10. Heaney AP, Melmed S (2004) Molecular targets in pituitary tumors. Nat Rev Cancer 4: 285-295, doi:10.1038/nrc1320
11. Jenkins PJ (2004) Acromegaly and cancer. Horm Res 62(S1): 108-115, doi:10.1159/000080768
12. Jenkins PJ, Mukherjeet A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocr 64: 115-121, doi:10.1111/j.1365-2265.2005. 02404.x
13. Khoo US, Ozcelik H, Cheung AN (1999) Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 18: 4643-4646
14. Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr-Relat Cancer 10: 437-450
15. Li J, Yen C, Liaw D (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, doi: 10.1126/science.275.5308.1943
16. Marlowe JL, Puga A (2005) Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96: 1174-1184, doi: 10.1002/jcb.20656
17. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M (1995) Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocr Metab 80: 3395-3402
18. Meyer BK, Perdew GH (1999) Characterization of the AhR-hsp90-XAP2 core complex and the role of the Immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38: 8907-8917, doi: 10.1021/bi982223w
19. Naderi A, Couch FJ (2002) BRCA2 and pancreatic cancer. Int J Gastrointest Cancer 31: 99-106
20. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
21. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A: 492-497
22. Pollenz RS, Dougherty EJ (2005) Redefining the role of the endogenous XAP2 and C-terminal hsp70-interacting protein on the endogenous Ah receptors expressed in mouse and rat cell lines. J Biol Chem 280: 33346-33356, doi:10.1074/jbc.M506619200
23. Salovaara R, Loukola A, Kristo P (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18: 2193-2200
24. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG, Sidransky D (2002) Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62: 3659-3662
25. Sjöblom T, Jones S, Wood LD (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274, doi: 10.1126/science.1133427
26. Sumanasekera WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH (2003) Evidence that peroxisome proliferator-activated receptor á is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J Biol Chem 278: 4467-4473, doi:10.1074/jbc.M211261200
27. Vierimaa O, Georgitsi M, Lehtonen R (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312: 1228- 1230, doi: 10.1126/science.1126100
28. Waltering KK, Wallén MJ, Tammela TLJ, Vessella RL, Visakorpi T (2006) Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer. Prostate 66: 1585-1591, doi: 10.1002/pros.20387
29. Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 2660-2664
30. Yang Q, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Umemura T, Mori I, Sakurai T, Kakudo K (2002) BRCA1 in non-inherited breast carcinomas. Oncol Rep 9: 1329-1333